1. Anti‐C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model. (13th August 2018) Authors: Batsuli, G.; Ito, J.; Mercer, R.; Baldwin, W. H.; Cox, C.; Parker, E. T.; Healey, J. F.; Lollar, P.; Meeks, S. L. Journal: Journal of thrombosis and haemostasis Issue: Volume 16:Number 9(2018) Page Start: 1779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene. (8th January 2016) Authors: Chao, B. N.; Baldwin, W. H.; Healey, J. F.; Parker, E. T.; Shafer‐Weaver, K.; Cox, C.; Jiang, P.; Kanellopoulou, C.; Lollar, P.; Meeks, S. L.; Lenardo, M. J. Journal: Journal of thrombosis and haemostasis Issue: Volume 14:Number 2(2016:Feb.) Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗